Directory Home
Researchers
Departments
Publications
Projects
Activities
Datasets
Home
>
Research
>
Projects
>
MSI: Patient-specific technologies for drug del...
Research
Research at Lancaster
Researchers
Departments & Centres
Publications & Outputs
Projects
Activities
Datasets
View graph of relations
MSI: Patient-specific technologies for drug delivery, tissue regeneration and fighting microbial infection
Project
:
Research
Status
Finished
Effective start/end date
1/06/19
→
31/12/19
Funding
The British Council:
£50,236.00
Douglas, Timothy
(Principal Investigator)
Research outputs
pH-sensitive dairy-derived hydrogels with a prolonged drug release profile for cancer treatment
Research output
:
Contribution to Journal/Magazine
›
Journal article
›
peer-review